本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aligos Therapeutics, Inc.

5.04
-0.1800-3.45%
盤後5.040.00000.00%19:30 EDT
成交量:2.80萬
成交額:14.35萬
市值:3,147.28萬
市盈率:-0.69
高:5.27
開:5.17
低:5.02
收:5.22
52周最高:13.69
52周最低:3.98
股本:624.46萬
流通股本:370.27萬
量比:0.70
換手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-7.3016
每股收益(LYR):-2.4500
淨資產收益率:-113.59%
總資產收益率:-49.12%
市淨率:0.99
市盈率(LYR):-2.06

資料載入中...

2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/31

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/01/06

重要事件披露

8-K - Current report
2021/11/18

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/28

SEC問詢函

CORRESP [Cover] - Correspondence
2021/06/28

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/24

重要事件披露

8-K - Current report
2021/06/24

重要事件披露

8-K/A [Amend] - Current report
2021/06/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership